These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 33006481)
1. CircEXOC6B Suppresses the Proliferation and Motility and Sensitizes Ovarian Cancer Cells to Paclitaxel Through miR-376c-3p/FOXO3 Axis. Zheng Y; Li Z; Yang S; Wang Y; Luan Z Cancer Biother Radiopharm; 2022 Nov; 37(9):802-814. PubMed ID: 33006481 [No Abstract] [Full Text] [Related]
2. Circ_0025033 deficiency suppresses paclitaxel resistance and malignant development of paclitaxel-resistant ovarian cancer cells by modulating the miR-532-3p/FOXM1 network. Huang H; Yan L; Zhong J; Hong L; Zhang N; Luo X Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):275-286. PubMed ID: 35196944 [TBL] [Abstract][Full Text] [Related]
3. miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation. Salem M; Shan Y; Bernaudo S; Peng C Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013711 [TBL] [Abstract][Full Text] [Related]
4. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p. Zang H; Li Y; Zhang X; Huang G Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273 [TBL] [Abstract][Full Text] [Related]
5. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway. Zhang C; Li Y; Zhao W; Liu G; Yang Q Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655 [TBL] [Abstract][Full Text] [Related]
6. Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis. Lu H; Zheng G; Gao X; Chen C; Zhou M; Zhang L J Ovarian Res; 2021 Feb; 14(1):30. PubMed ID: 33563314 [TBL] [Abstract][Full Text] [Related]
7. Circ_0,007,331 Promotes the PTX Resistance and Progression of Breast Cancer via miR-200b-3p/ANLN. Yang C; Liu L; Gao C; Zhang G; Zhang Y; Zhang S; Li J; Liu Y J Surg Res; 2022 Nov; 279():619-632. PubMed ID: 35926312 [TBL] [Abstract][Full Text] [Related]
8. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis. Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291 [TBL] [Abstract][Full Text] [Related]
9. MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B. Niu Q; Liu Z; Gao J; Wang Q Yonsei Med J; 2019 Dec; 60(12):1146-1156. PubMed ID: 31769245 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis. Wei S; Qi L; Wang L Anticancer Drugs; 2021 Jun; 32(5):496-507. PubMed ID: 33735118 [TBL] [Abstract][Full Text] [Related]
11. Circ_0000274 contributes to renal cell carcinoma progression by regulating miR-338-3p/NUCB2 axis and JAK1/STAT3 pathway. Qi Q; Sun Y; Yang Y; Liu Y Transpl Immunol; 2022 Oct; 74():101626. PubMed ID: 35569717 [TBL] [Abstract][Full Text] [Related]
12. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p. Liu YY; Zhang LY; Du WZ Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989 [TBL] [Abstract][Full Text] [Related]
13. CircWHSC1 serves as an oncogene to promote hepatocellular carcinoma progression. Lyu P; Zhai Z; Hao Z; Zhang H; He J Eur J Clin Invest; 2021 Jun; 51(6):e13487. PubMed ID: 33410156 [TBL] [Abstract][Full Text] [Related]
14. Circular RNA circFOXO3 facilitate non-small cell lung cancer progression through upregulating HMGB3 via sponging miR-545-3p/miR-506-3p. Yang M; Zheng E; Ni J; Xu X; Jiang X; Zhao G Tissue Cell; 2022 Apr; 75():101702. PubMed ID: 35038619 [TBL] [Abstract][Full Text] [Related]
15. Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis. Liu T; Yuan L; Zou X J Ovarian Res; 2022 Aug; 15(1):95. PubMed ID: 35965327 [TBL] [Abstract][Full Text] [Related]
16. Circular RNA circFADS2 inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-766-3p/HOXA9 axis. Zhang Z; Sun H; Hou J; Li L; Wu L Histol Histopathol; 2022 Apr; 37(4):335-348. PubMed ID: 34913472 [TBL] [Abstract][Full Text] [Related]
17. Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer. Zhu J; Luo JE; Chen Y; Wu Q J Ovarian Res; 2021 Oct; 14(1):136. PubMed ID: 34649611 [TBL] [Abstract][Full Text] [Related]
18. CircSETDB1 contributes to paclitaxel resistance of ovarian cancer cells by sponging miR-508-3p and regulating ABCC1 expression. Huang C; Qin L; Chen S; Huang Q Anticancer Drugs; 2023 Mar; 34(3):395-404. PubMed ID: 36729852 [TBL] [Abstract][Full Text] [Related]
19. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis. Li Z; Yao H; Wang S; Li G; Gu X J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-29c-3p participates in insulin function to modulate polycystic ovary syndrome via targeting Forkhead box O 3. Chen H; Fu Y; Guo Z; Zhou X Bioengineered; 2022 Feb; 13(2):4361-4371. PubMed ID: 35142592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]